Comparison of predictive powers of functional and anatomic dosimetric parameters for radiation-induced lung toxicity in locally advanced non-small cell lung cancer. Issue 2 (November 2018)
- Record Type:
- Journal Article
- Title:
- Comparison of predictive powers of functional and anatomic dosimetric parameters for radiation-induced lung toxicity in locally advanced non-small cell lung cancer. Issue 2 (November 2018)
- Main Title:
- Comparison of predictive powers of functional and anatomic dosimetric parameters for radiation-induced lung toxicity in locally advanced non-small cell lung cancer
- Authors:
- Xiao, Linlin
Yang, Guoren
Chen, Jinhu
Yang, Yuchen
Meng, Xue
Wang, Xiaohui
Wu, Qingwei
Huo, Zongwei
Yu, Qingxi
Yu, Jinming
Kong, Feng-Ming (Spring)
Yuan, Shuanghu - Abstract:
- Highlights: Conventionally, metrics of pre-radiotherapy (RT) pulmonary function or post-RT pulmonary function changes have been used to predict outcomes in lung cancer patients receiving RT, but we hypothesized that parameters evaluated mid-treatment and used for replanning could provide accurate prediction of subsequent radiation-induced lung toxicity (RILT). In the presented study, we tested this hypothesis in 42 patients receiving RT for high-risk, locally advanced non-small cell lung cancer (NSCLC) Perfusion (Q)-single-photon emission computed tomography (SPECT) and Q-SPECT-CT were performed prior to RT and mid-treated after delivery of 40–50 Gy RT. Our findings suggest that the mid-Tx dose–function histogram (DFH) parameters based on Q-SPECT were significantly elevated in patients who experienced grade 2 and above RILT. Mid-Tx DFH seemed to be better for predicting RILT than traditional anatomical metrics in locally advanced NSCLC patients with significant functional lung changes mid-RT, though the difference did not reach a significant level, likely due to the limited sample size in this study. Abstract: Purpose: To investigate the predictive value of the perfusion (Q) single-photon emission computed tomography (SPECT)-weighted dose–function histogram (DFH) obtained mid-treatment (mid-Tx) with radiotherapy (RT) for radiation-induced lung toxicity (RILT) in patients with non-small cell lung cancer (NSCLC). Materials and methods: The study population consisted of NSCLCHighlights: Conventionally, metrics of pre-radiotherapy (RT) pulmonary function or post-RT pulmonary function changes have been used to predict outcomes in lung cancer patients receiving RT, but we hypothesized that parameters evaluated mid-treatment and used for replanning could provide accurate prediction of subsequent radiation-induced lung toxicity (RILT). In the presented study, we tested this hypothesis in 42 patients receiving RT for high-risk, locally advanced non-small cell lung cancer (NSCLC) Perfusion (Q)-single-photon emission computed tomography (SPECT) and Q-SPECT-CT were performed prior to RT and mid-treated after delivery of 40–50 Gy RT. Our findings suggest that the mid-Tx dose–function histogram (DFH) parameters based on Q-SPECT were significantly elevated in patients who experienced grade 2 and above RILT. Mid-Tx DFH seemed to be better for predicting RILT than traditional anatomical metrics in locally advanced NSCLC patients with significant functional lung changes mid-RT, though the difference did not reach a significant level, likely due to the limited sample size in this study. Abstract: Purpose: To investigate the predictive value of the perfusion (Q) single-photon emission computed tomography (SPECT)-weighted dose–function histogram (DFH) obtained mid-treatment (mid-Tx) with radiotherapy (RT) for radiation-induced lung toxicity (RILT) in patients with non-small cell lung cancer (NSCLC). Materials and methods: The study population consisted of NSCLC patients who were undergoing RT treatment and enrolled in prospective imaging studies. Q-SPECT was performed prior to and during RT (at ∼40–45 Gy). A baseline dose–volume histogram (DVH) and mid-Tx DVH based on simulation CT as well as a baseline DFH and mid-Tx DFH based on Q-SPECT were calculated. Only patients with stage III NSCLC and visible functional lung (FL) changes on the mid-Tx scan were eligible for this enriched analysis. RILT was graded according to a reported scale. Results: Forty-two stage III NSCLC patients met the criteria for inclusion. The accumulative incidence of grade ≥2 RILT was 31% in this high-risk population. Significant differences in functional metrics such as functional lung volume FV5–FV20 at increments of 5 Gy and functional MLD (FMLD) were observed between patients with and without grade ≥2 RILT ( p < 0.05). Similar results were also obtained for anatomical metrics from V5–V20 and MLD ( p < 0.05). The areas under the receiver operating characteristic curves (AUCs) ranged from 0.724to 0.812 for baseline DVH parameters, from 0.745 to 0.830 for mid-Tx DVH parameters, from 0.764 to 0.878 for baseline DFH parameters, and from 0.767 to 0.891 for mid-Tx DFH parameters. Further principal components analysis showed that the AUCs were 0.814/0.817 and 0.790/0.857 for baseline/mid-Tx DVH and baseline/mid-Tx DFH, respectively. Conclusions: Mid-Tx DFH parameters based on Q-SPECT were significantly elevated in patients with grade ≥2 RILT in this study population. Among the metrics compared, mid-Tx DFH seemed to have better predictive accuracy, but this difference did not reach statistical difference. … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 129:Issue 2(2018)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 129:Issue 2(2018)
- Issue Display:
- Volume 129, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 129
- Issue:
- 2
- Issue Sort Value:
- 2018-0129-0002-0000
- Page Start:
- 242
- Page End:
- 248
- Publication Date:
- 2018-11
- Subjects:
- NSCLC -- Radiation-induced lung toxicity -- Q-SPECT -- DVH -- DFH
Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2018.09.005 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8663.xml